BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21059874)

  • 1. Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen.
    Maddry JA; Chen X; Jonsson CB; Ananthan S; Hobrath J; Smee DF; Noah JW; Noah D; Xu X; Jia F; Maddox C; Sosa MI; White EL; Severson WE
    J Biomol Screen; 2011 Jan; 16(1):73-81. PubMed ID: 21059874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2).
    Severson WE; McDowell M; Ananthan S; Chung DH; Rasmussen L; Sosa MI; White EL; Noah J; Jonsson CB
    J Biomol Screen; 2008 Oct; 13(9):879-87. PubMed ID: 18812571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
    Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
    J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
    Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
    Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis.
    Takizawa N; Kimura T; Watanabe T; Shibasaki M
    Arch Virol; 2018 Jun; 163(6):1607-1614. PubMed ID: 29497849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro efficacy of Ingavirin against the pandemic influenza virus A(H1N1/09)v].
    Shishkina LN; Nebol'sin VE; Kabanov AS; Skarnovich MO; Erdyneeva UB; Mazurkova NA; Serova OA; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(3-4):12-6. PubMed ID: 20695202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v].
    Shishkina LN; Nebol'sin VE; Kabanov AS; Skarnovich MO; Mazurkova NA; Sergeev AA; Serova OA; Stavskiĭ EA; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):93-6. PubMed ID: 21598625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
    Muratore G; Goracci L; Mercorelli B; Foeglein Á; Digard P; Cruciani G; Palù G; Loregian A
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6247-52. PubMed ID: 22474359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
    Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
    Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
    Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
    Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
    Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
    Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.
    Hsu JT; Yeh JY; Lin TJ; Li ML; Wu MS; Hsieh CF; Chou YC; Tang WF; Lau KS; Hung HC; Fang MY; Ko S; Hsieh HP; Horng JT
    Antimicrob Agents Chemother; 2012 Feb; 56(2):647-57. PubMed ID: 21930871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen.
    Yao Y; Kadam RU; Lee CD; Woehl JL; Wu NC; Zhu X; Kitamura S; Wilson IA; Wolan DW
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18431-18438. PubMed ID: 32690700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
    Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
    Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-influenza activities of polyphenols from the medicinal mushroom Phellinus baumii.
    Hwang BS; Lee IK; Choi HJ; Yun BS
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3256-60. PubMed ID: 26077494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
    Adcock RS; Chu YK; Golden JE; Chung DH
    Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.
    Smee DF; Hurst BL; Day CW
    Antivir Chem Chemother; 2012 Aug; 22(6):263-72. PubMed ID: 22516927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture].
    Fediakina IT; Shchelkanov MIu; Deriabin PG; Leneva IA; Gudova NV; Kondrat'eva TV; L'vov DK
    Antibiot Khimioter; 2011; 56(3-4):3-9. PubMed ID: 21913403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
    Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
    J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.